RenovoRx Inc

RenovoRx Inc

RNXT

Get informed when a big investor buys or sells

+ Follow
Market Cap$35.67M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
RenovoRx IncRenovoRx Inc-2.9--109%--
$0.36

Current Fair Value

65.6% downside

Overvalued by 65.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$35.67 Million
Enterprise Value$23.39 Million
Dividend Yield$- (-)
Earnings per Share$-0.32
Beta0.99
Outstanding Shares38,032,421

Return

Return on Equity-108.91%ROE
Return on Assets-87.86%
Return on Invested Capital-106.85%

Valuation & Multiples

P/E Ratio-2.86P/E Ratio
PEG-6.28PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue15.71
Enterprise Value to EBIT-1.82
Enterprise Value to Net Income-2
Total Debt to Enterprise0
Debt to Equity0.01Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 21, 2026
EPS Estimate
$-0.08
Average shareholder expectation
Revenue Estimate
$469,500
Average shareholder expectation

Next Earnings Call

Expected Date
August 12, 2026
EPS Estimate
$-0.08
Average shareholder expectation
Revenue Estimate
$703,750
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %22.52% 3.91%
Total Invested$8.58M 25.68%
Investors Holding31 2.00%

ESG Score

No data

About RenovoRx Inc

2,021 employees